跳至主要内容
临床试验/NCT04638816
NCT04638816已完成不适用

A Study Comparing Hyaluronic Acid Effectiveness & Evaluating Cheek Results With Restylane

Galderma R&D3 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2021年4月16日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Galderma R&D
入组人数
60
试验地点
3
主要终点
Assess Treatment With Restylane Volyme and Restylane Lyft Lidocaine Using GAIS

研究概览

简要总结

Open-label, phase IV, post-marketing study to evaluate aesthetic improvement and satisfaction after treatment with Restylane

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Signed and dated informed consent to participate in the study
  • Adult women who intend to undergo cheek augmentation

排除标准

  • Subjects presenting with known allergy to HA (hyaluronic acid) filler or amide local anesthetics
  • Subjects with a previous implant other than HA in or near the intended treatment site
  • Participation in any other clinical study within three (3) months before treatment

结局指标

主要结局

Assess Treatment With Restylane Volyme and Restylane Lyft Lidocaine Using GAIS

时间窗: 4 weeks after last treatment, up to 6 weeks

The 7-grade Global Aesthetic Improvement Scale (GAIS) assess the appearance of the treatment area (cheeks) compared to pre-treatment. The rating is very much improved, much improved, improved, no change, worse, much worse, or very much worse.

次要结局

未报告次要终点

研究者

发起方
Galderma R&D
申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验